Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shayman, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shayman, J. A.

Journal of the American Society of Nephrology, Vol 7, 171-182, Copyright © 1996 by American Society of Nephrology

REVIEWS

Sphingolipids: their role in intracellular signaling and renal growth

JA Shayman

Glycerophospholipids have long been recognized as substrates for the formation of important intracellular second messengers. Recently, another class of membrane-associated lipids, sphingolipids, has been identified as potentially important in cell-signaling events. Ceramides, long-chain bases, and sphingosine derivatives may be mediators of cellular growth, differentiation, and programmed death responses. These lipids have been proposed to act through the regulation of cell kinases, phosphatases, and gene transcription. Observations of sphingolipid abnormalities in two examples of aberrant renal growth, diabetes mellitus and autosomal recessive kidney disease, suggest that sphingolipids may play a role in the pathophysiology of common renal disorders.


This article has been cited by other articles:


Home page
 BloodHome page
P. J. Mansfield, S. S. Carey, V. Hinkovska-Galcheva, J. A. Shayman, and L. A. Boxer
Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTP{gamma}S-stimulated polymorphonuclear leukocytes
Blood, March 15, 2004; 103(6): 2363 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. Wang, R. T. Riley, F. I. Meredith, and A. H. Merrill Jr.
Fumonisin B1 Consumption by Rats Causes Reversible, Dose-Dependent Increases in Urinary Sphinganine and Sphingosine
J. Nutr., January 1, 1999; 129(1): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Chatterjee
Sphingolipids in Atherosclerosis and Vascular Biology
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1523 - 1533.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673